Please provide your email address to receive an email when new articles are posted on . A 60-year-old man presented with right thigh pain for the past 3 months. He also noted a mass progressively ...

The metastatic incidence of retroperitoneal dedifferentiated liposarcoma is comparatively lower than other pleomorphic sarcomas, varying widely from 1 to 18%. Low-grade dedifferentiation resembling ...

Liposarcoma is cancer that starts in the fat cells. It is a type of soft tissue sarcoma. A liposarcoma can grow anywhere but most often develops in the abdomen or limbs. Liposarcoma is among the most ...

Now that you've gotten your diagnosis of liposarcoma, a type of cancer that starts in fat cells, it's time to learn how to best manage your doctor's visits and deal with treatment side effects. It's ...

Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with ...

New York, USA, May 27, 2025 (GLOBE NEWSWIRE) -- Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The liposarcoma treatment ...

Background Liposarcoma (LS) is the second-most common type of soft-tissue sarcoma. Despite advances in knowledge and treatment of this disease, there remains a need for more effective LS therapy.

This patient's prognosis was relatively good because the size of his tumor was less than 10 cm, although he also had poor prognostic features, such as the deep location of the tumor and its high-grade ...

Toronto Mayor Rob Ford has been diagnosed with an extremely rare and fast-growing cancer, called pleomorphic liposarcoma, one of his doctors announced yesterday (Sept. 17). Dr. Zane Cohen, one of the ...

In this study, we present the establishment and characterization of a new MLS cell line (DL-221), which to our knowledge is the first spontaneously immortalized cell line of this tumor type. This was ...

Impact of age on treatment and survival in soft tissus sarcoma. A study of 1568 sarcomas from the French Sarcoma Group No significant financial relationships to disclose. This is an ASCO Meeting ...